Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics
Sangamo Therapeutics, Inc. (SGMO)
Today's Latest Price: $10.12 USD
Updated Nov 27 1:00pm
Add SGMO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SGMO Stock Summary
- Of note is the ratio of Sangamo Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 15.14% of US stocks have a lower such ratio.
- SGMO's price/sales ratio is 9.72; that's higher than the P/S ratio of 84.95% of US stocks.
- Revenue growth over the past 12 months for Sangamo Therapeutics Inc comes in at 97.87%, a number that bests 94.54% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Sangamo Therapeutics Inc, a group of peers worth examining would be GLYC, DTIL, SRRK, CMRX, and ALPN.
- Visit SGMO's SEC page to see the company's official filings. To visit the company's web site, go to www.sangamo.com.
SGMO Stock Price Chart Interactive Chart >
SGMO Price/Volume Stats
| Current price | $10.12 | 52-week high | $13.20 |
| Prev. close | $9.77 | 52-week low | $4.81 |
| Day low | $9.81 | Volume | 1,103,000 |
| Day high | $10.13 | Avg. volume | 1,990,243 |
| 50-day MA | $10.60 | Dividend yield | N/A |
| 200-day MA | $9.69 | Market Cap | 1.43B |
Sangamo Therapeutics, Inc. (SGMO) Company Bio
Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. The company was founded in 1995 and is based in Richmond, California.
Loading social stream, please wait...